Skip to main content

New Products

  • PDX, OmniChannel Health Media partner on patient diabetes education efforts

    FORT WORTH, Texas — PDX and OmniChannel Health Media on Wednesday announced a new partnership that will offer PDX Manufacturer Services retail pharmacy network customers new options to engage and educate patients with diabetes and prediabetes. 
     
    The two companies are working with commercial health insurers, digital health providers, manufacturers and the government to bring tools for diabetes prevention and management to pharmacy customers. 
     
  • Drive DeVilbiss Healthcare launches home health solutions for special needs pediatrics

    PORT WASHINGTON, N.Y. – Drive DeVilbiss Healthcare last week officially launched a new home health lineup targeting children with special needs branded "Inspired by Drive."

    "The new brand was born out of a passion for making a positive impact on the lives of children with special needs and their families," stated Doug Francis, principal and co-founder of Drive DeVilbiss Healthcare. "Inspired by Drive" joins the Columbia Medical, Specialised Orthotic Services (U.K.) and Wenzelite Rehab brands into one, the company noted.

  • Age, smartphone usage awaken sales

    Overall, the sale of all sleep remedies were up 6.1% to $707.9 million across total U.S. multi-outlets for the 52 weeks ended Nov. 27, 2016, according to IRI. Procter & Gamble’s ZzzQuil still leads the category. Sales of the liquid formulation are outpacing category growth with an uptick of 8.4% to $85.3 million, or 12% of total category sales.

    (To view the full Cough-Cold Report, click here.)

  • The ‘humanization’ of pets

    Americans can’t do enough for their furry friends. To that end, growth continues to be the watchword in the pet care category.

    Research released by the American Pet Products Association, or the APPA, indicated that American consumers would spend a total of $62.75 billion on pet supplies and care in 2016, up from $60.28 in 2015 and $58.04 in 2014.

  • New contenders, category heavyweights battle for top spot in cough-cold

    Last year, Drug Store News projected that GSK Consumer Healthcare’s Flonase allergy franchise would be challenged with the introduction of two new nasal corticosteroids to the market — McNeil Consumer’s Rhinocort and Bayer’s ClariSpray.

    (To view the full Cough-Cold Report, click here.)

  • En-Vision America expands offerings

    Since it launched its ScripTalk audible labels, En-Vision America has worked to make prescription labels more accessible for patients who might be visually impaired and thus require an audible label, larger print label or Braille label. And this year, the company is expanding its accessibility by offering label translations into 17 languages.

X
This ad will auto-close in 10 seconds